Technical Analysis for NVO - Novo Nordisk A/S
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Historical NVO trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Stochastic Sell Signal | Bearish | 0.00% | |
| Cup with Handle | Other | 0.00% | |
| Doji - Bearish? | Reversal | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Upper Bollinger Band Walk | Strength | -0.11% | |
| Above Upper BB | Strength | -0.11% | |
| Overbought Stochastic | Strength | -0.11% | |
| Up 3 Days in a Row | Strength | -0.11% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakout | about 9 hours ago |
| Rose Above Previous Day's High | about 9 hours ago |
| Fell Below Upper Bollinger Band | about 10 hours ago |
| 60 Minute Opening Range Breakout | 1 day ago |
| Up 1% | 1 day ago |
Free Daily (Stock) Chart Reading
- Earnings date: ???
Novo Nordisk A/S Description
Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth hormone therapy, hormone replacement therapy, and inflammation. The company sells its products primarily in North America, China, Japan, Algeria, Argentina, Australia, Brazil, India, Turkey, and European countries through its subsidiaries, distributors, and independent agents. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Life Sciences Diabetes Pharmaceutical Products Inflammation Endocrine System Insulin Hormones Obesity Biopharmaceuticals Peptide Hormones Growth Hormone Glucagon Like Peptide 1 Pharmaceuticals Segment Anti Diabetic Drugs Diabetes Care Growth Hormone Therapy Haemophilia Hormone Therapy Novo Nordisk Related Delivery Systems
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 75.8601 |
| 52 Week Low | 61.53 |
| Average Volume | 945,717 |
| 200-Day Moving Average | 69.16 |
| 50-Day Moving Average | 71.08 |
| 20-Day Moving Average | 69.96 |
| 10-Day Moving Average | 71.89 |
| Average True Range | 1.07 |
| ADX | 20.64 |
| +DI | 39.74 |
| -DI | 17.32 |
| Chandelier Exit (Long, 3 ATRs ) | 71.29 |
| Chandelier Exit (Short, 3 ATRs ) | 69.81 |
| Upper Bollinger Band | 74.50 |
| Lower Bollinger Band | 65.41 |
| Percent B (%b) | 0.96 |
| BandWidth | 13.00 |
| MACD Line | 0.92 |
| MACD Signal Line | 0.26 |
| MACD Histogram | 0.6688 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 75.12 | ||||
| Resistance 3 (R3) | 75.13 | 74.82 | 74.96 | ||
| Resistance 2 (R2) | 74.82 | 74.57 | 74.82 | 74.91 | |
| Resistance 1 (R1) | 74.49 | 74.42 | 74.33 | 74.47 | 74.85 |
| Pivot Point | 74.17 | 74.17 | 74.09 | 74.17 | 74.17 |
| Support 1 (S1) | 73.84 | 73.93 | 73.68 | 73.83 | 73.45 |
| Support 2 (S2) | 73.52 | 73.77 | 73.52 | 73.39 | |
| Support 3 (S3) | 73.19 | 73.52 | 73.34 | ||
| Support 4 (S4) | 73.18 |
